These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22264761)

  • 1. 6-Nitrobenzimidazole derivatives: potential phosphodiesterase inhibitors: synthesis and structure-activity relationship.
    Khan KM; Shah Z; Ahmad VU; Ambreen N; Khan M; Taha M; Rahim F; Noreen S; Perveen S; Choudhary MI; Voelter W
    Bioorg Med Chem; 2012 Feb; 20(4):1521-6. PubMed ID: 22264761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors.
    Kehler J; Ritzen A; Langgård M; Petersen SL; Farah MM; Bundgaard C; Christoffersen CT; Nielsen J; Kilburn JP
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3738-42. PubMed ID: 21602043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel benzimidazole derivatives as phosphodiesterase 10A inhibitors with reduced CYP1A2 inhibition.
    Hamaguchi W; Masuda N; Isomura M; Miyamoto S; Kikuchi S; Amano Y; Honbou K; Mihara T; Watanabe T
    Bioorg Med Chem; 2013 Dec; 21(24):7612-23. PubMed ID: 24238902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability.
    Chino A; Masuda N; Amano Y; Honbou K; Mihara T; Yamazaki M; Tomishima M
    Bioorg Med Chem; 2014 Jul; 22(13):3515-26. PubMed ID: 24837154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors.
    Asproni B; Murineddu G; Pau A; Pinna GA; Langgård M; Christoffersen CT; Nielsen J; Kehler J
    Bioorg Med Chem; 2011 Jan; 19(1):642-9. PubMed ID: 21087867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of hydroxamic acid analogs as dual inhibitors of phosphodiesterase-1 and -5.
    Dan A; Shiyama T; Yamazaki K; Kusunose N; Fujita K; Sato H; Matsui K; Kitano M
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4085-90. PubMed ID: 16005625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cAMP-dependent phosphodiesterase inhibition of novel thiazoloquinazoline derivatives.
    Selvam TP; Kumar PV
    Acta Pharm; 2011 Mar; 61(1):103-13. PubMed ID: 21406348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of 6-(benzyloxy)-4-methylquinolin-2(1H)-one derivatives as PDE3 inhibitors.
    Nikpour M; Sadeghian H; Saberi MR; Nick RS; Seyedi SM; Hosseini A; Parsaee H; Bozorg AT
    Bioorg Med Chem; 2010 Jan; 18(2):855-62. PubMed ID: 20005117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors.
    Song B; Xiao T; Qi X; Li LN; Qin K; Nian S; Hu GX; Yu Y; Liang G; Ye F
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1739-42. PubMed ID: 22257893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4.
    Ruchelman AL; Man HW; Chen R; Liu W; Lu L; Cedzik D; Zhang L; Leisten J; Collette A; Narla RK; Raymon HK; Muller GW
    Bioorg Med Chem; 2011 Nov; 19(21):6356-74. PubMed ID: 21955454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.
    Li YF; Wang GF; Luo Y; Huang WG; Tang W; Feng CL; Shi LP; Ren YD; Zuo JP; Lu W
    Eur J Med Chem; 2007; 42(11-12):1358-64. PubMed ID: 17499889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety.
    Zakharenko A; Khomenko T; Zhukova S; Koval O; Zakharova O; Anarbaev R; Lebedeva N; Korchagina D; Komarova N; Vasiliev V; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
    Bioorg Med Chem; 2015 May; 23(9):2044-52. PubMed ID: 25819333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
    Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
    Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity.
    Biagini P; Biancalani C; Graziano A; Cesari N; Giovannoni MP; Cilibrizzi A; Dal Piaz V; Vergelli C; Crocetti L; Delcanale M; Armani E; Rizzi A; Puccini P; Gallo PM; Spinabelli D; Caruso P
    Bioorg Med Chem; 2010 May; 18(10):3506-17. PubMed ID: 20413313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e]purin-4(3H)-one derivatives.
    Xia G; Li J; Peng A; Lai S; Zhang S; Shen J; Liu Z; Chen X; Ji R
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2790-4. PubMed ID: 15878277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel urolithins derivatives as potential phosphodiesterase II inhibitors.
    Tang L; Jiang J; Song G; Wang Y; Zhuang Z; Tan Y; Xia Y; Huang X; Feng X
    Sci Rep; 2021 Dec; 11(1):23792. PubMed ID: 34893678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.
    Sahoo PK; Behera P
    Eur J Med Chem; 2010 Mar; 45(3):909-14. PubMed ID: 19962793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking.
    Khan KM; Rahim F; Halim SA; Taha M; Khan M; Perveen S; Zaheer-Ul-Haq ; Mesaik MA; Iqbal Choudhary M
    Bioorg Med Chem; 2011 Jul; 19(14):4286-94. PubMed ID: 21684753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
    Singh M; Tandon V
    Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of phosphodiesterase-1 and 5 dual inhibitors by a ligand-based virtual screening optimized for lead evolution.
    Yamazaki K; Kusunose N; Fujita K; Sato H; Asano S; Dan A; Kanaoka M
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1371-9. PubMed ID: 16337379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.